Worldwide, nearly 44 million people have Alzheimer’s Disease. By 2025, the number of people age 65 and older with Alzheimer’s Disease is estimated to increase 40%
Emma is a family of products that aims to help people suffering from Alzheimer's maintain their independence and dignity throughout the progression of the disease.
Emma uses EEG brain sensors to read brainwaves and sense confusion. This allows Emma to help when help is needed and passively monitor the patient's activities when help is not needed. Emma learns and grows with the patient to provide the best care throughout the progression of the disease.
VISUAL & AUDIO INSTRUCTIONS
Transparent AR display shows information in context to the user’s surroundings using graphic overlays. Emma speaks to the Alzheimer’s patient through bone conduction speakers. This allows the user to listen to Emma while still being able to hear their surroundings.
UNDERSTANDING THE CONTEXT
The two front-facing cameras let Emma understand the user's situation by using image recognition technology.
ALWAYS BY YOUR SIDE
Emma speaks to the Alzheimer's patient through the speakers in the bracelet when the patient is not wearing the glasses. The bracelet has RFID sensors that can scan medications and other things around the house.
We included a feature that allows family members to send gentle squeezes to the Alzheimer’s patient. The elastomeric polymer inside the strap contracts to simulate a gentle squeeze from their loved ones. The gentle squeeze provides positive reinforcement by reminding the patient that their family members are thinking about him/her when they are separated.
Emma View is placed on the charging pad before going to sleep. Induction charging technology is used so that the user can build a relationship with Emma View as if they were a normal pair of glasses. The user can naturally place the glasses onto the charging pad rather than connecting the glasses to a charging cable.
COMMUNICATION BETWEEN DEVICES
When the caregiver receives Emma, he/she will be able to set up the patient's info (i.e. their name, doses of medication, cognitive developing quiz questions, and daily schedule). Emma View will send medication updates back to the caregiver's smartphone to notify them that their patient is on track. The quiz results will be sent back to the caregiver and doctor to keep them updated on the progression of the disease.
TOTAL DEPENDENCE (POST MODERATE STAGES)
There will be a time when the Alzheimer’s patient needs to be fully dependent on a caregiver. After the moderate stages have passed, EMMA and the data that has been collected are then handed over to their caregiver. It informs the caregiver of the patient’s habits and routines to provide the best care for the individual.